Back
F/m US Treasury 3 Year Note ETF Vs. Olema Pharmaceuticals, Inc. Industry Stock Comparison
Sell
30
UTRE
F/m US Treasury 3 Year Note ETF
Last Price:
$49.49
Seasonality Move:
-0.34%
Sell
35
OLMA
Olema Pharmaceuticals, Inc.
Last Price:
$15.07
Seasonality Move:
35.67%
Sell
30
F/m US Treasury 3 Year Note ETF (UTRE)
is a Sell
Is F/m US Treasury 3 Year Note ETF a Buy, Sell or Hold?
-
The current F/m US Treasury 3 Year Note ETF [UTRE] share price is $49.49. The Score for UTRE is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
UTRE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Olema Pharmaceuticals, Inc. (OLMA)
is a Sell
Is Olema Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Olema Pharmaceuticals, Inc. [OLMA] share price is $15.06. The Score for OLMA is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
OLMA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
UTRE Stock Price Chart
What is F/m US Treasury 3 Year Note ETF's stock price today?
-
The F/m US Treasury 3 Year Note ETF share price today is $49.49Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTRE is experiencing buying pressure, which is a positive indicator for future bullish movement.
OLMA Stock Price Chart
What is Olema Pharmaceuticals, Inc.'s stock price today?
-
The Olema Pharmaceuticals, Inc. share price today is $15.06Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OLMA is experiencing buying pressure, which is a positive indicator for future bullish movement.
UTRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 12.98 | Buy |
| Relative Strength Index (14 RSI): | 43.01 | Sell |
| Chaikin Money Flow: | 4682 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.45 - 49.83) | Sell |
| Bollinger Bands (100): | (49.66 - 49.98) | Sell |
OLMA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.9 | Sell |
| Relative Strength Index (14 RSI): | 38.44 | Sell |
| Chaikin Money Flow: | 689032 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.07 - 20.59) | Sell |
| Bollinger Bands (100): | (16.26 - 29.18) | Sell |
UTRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.44 | Buy |
| 20-day SMA: | 49.57 | Sell |
| 50-day SMA: | 49.76 | Sell |
| 200-day SMA: | 49.78 | Sell |
| 8-day EMA: | 47.04 | Buy |
| 20-day EMA: | 34.58 | Buy |
| 50-day EMA: | 18.86 | Buy |
| 200-day EMA: | 5.59 | Buy |
OLMA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.3 | Buy |
| 20-day SMA: | 15.11 | Sell |
| 50-day SMA: | 20.74 | Sell |
| 200-day SMA: | 14.75 | Buy |
| 8-day EMA: | 14.64 | Buy |
| 20-day EMA: | 15.98 | Sell |
| 50-day EMA: | 19.08 | Sell |
| 200-day EMA: | 16.56 | Sell |
F/m US Treasury 3 Year Note ETF Earnings Growth & UTRE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Olema Pharmaceuticals, Inc. Earnings Growth & OLMA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.08 per share, a decrease this year of $0.37 per share, and a decrease next year of $0.26 per share.
F/m US Treasury 3 Year Note ETF Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Olema Pharmaceuticals, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||